| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.29e-08 | 37 | 50 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.78e-08 | 38 | 50 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.57e-06 | 79 | 50 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.25e-05 | 136 | 50 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.25e-05 | 136 | 50 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 1.08e-04 | 37 | 50 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 2.08e-04 | 46 | 50 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | nuclease activity | 2.75e-04 | 231 | 50 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 3.33e-04 | 11 | 50 | 2 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 5.49e-04 | 14 | 50 | 2 | GO:0003964 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 9.43e-04 | 303 | 50 | 5 | GO:0003713 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.25e-03 | 21 | 50 | 2 | GO:0035613 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.50e-03 | 23 | 50 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.55e-03 | 891 | 50 | 8 | GO:0005198 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 5.35e-05 | 85 | 50 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 5.35e-05 | 85 | 50 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 6.41e-05 | 89 | 50 | 4 | GO:0006949 | |
| GeneOntologyCellularComponent | clathrin complex | 2.00e-04 | 9 | 50 | 2 | GO:0071439 | |
| Domain | ArgoL1 | 8.85e-05 | 6 | 46 | 2 | PF08699 | |
| Domain | ArgoL1 | 8.85e-05 | 6 | 46 | 2 | IPR014811 | |
| Domain | PIWI | 1.65e-04 | 8 | 46 | 2 | PS50822 | |
| Domain | Piwi | 1.65e-04 | 8 | 46 | 2 | IPR003165 | |
| Domain | Piwi | 1.65e-04 | 8 | 46 | 2 | PF02171 | |
| Domain | Piwi | 1.65e-04 | 8 | 46 | 2 | SM00950 | |
| Domain | RFX_DNA_binding | 2.11e-04 | 9 | 46 | 2 | PF02257 | |
| Domain | PAZ | 2.11e-04 | 9 | 46 | 2 | PS50821 | |
| Domain | DNA-bd_RFX | 2.11e-04 | 9 | 46 | 2 | IPR003150 | |
| Domain | PAZ_dom | 2.11e-04 | 9 | 46 | 2 | IPR003100 | |
| Domain | RFX_DBD | 2.11e-04 | 9 | 46 | 2 | PS51526 | |
| Domain | PAZ | 2.11e-04 | 9 | 46 | 2 | PF02170 | |
| Domain | PAZ | 2.11e-04 | 9 | 46 | 2 | SM00949 | |
| Domain | RNaseH-like_dom | 6.54e-04 | 69 | 46 | 3 | IPR012337 | |
| Domain | PAS | 2.81e-03 | 32 | 46 | 2 | SM00091 | |
| Domain | PAS | 3.17e-03 | 34 | 46 | 2 | IPR000014 | |
| Domain | PAS | 3.17e-03 | 34 | 46 | 2 | PS50112 | |
| Domain | - | 5.98e-03 | 47 | 46 | 2 | 3.30.420.10 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 9.45e-05 | 6 | 36 | 2 | MM15083 | |
| Pathway | REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX | 1.12e-04 | 37 | 36 | 3 | M29790 | |
| Pathway | REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS | 1.32e-04 | 7 | 36 | 2 | M46421 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION | 2.26e-04 | 9 | 36 | 2 | M27810 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION | 2.26e-04 | 9 | 36 | 2 | M46436 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 2.30e-04 | 47 | 36 | 3 | M29777 | |
| Pathway | REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS | 2.82e-04 | 10 | 36 | 2 | M48013 | |
| Pathway | REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION | 4.86e-04 | 13 | 36 | 2 | M46434 | |
| Pathway | REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING | 5.03e-04 | 146 | 36 | 4 | M27288 | |
| Pathway | REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY | 8.42e-04 | 17 | 36 | 2 | M27788 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 9.46e-04 | 18 | 36 | 2 | M26942 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS | 1.06e-03 | 19 | 36 | 2 | M48238 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.89e-11 | 5 | 50 | 4 | 12629516 | |
| Pubmed | 1.85e-09 | 12 | 50 | 4 | 14557543 | ||
| Pubmed | 5.57e-08 | 6 | 50 | 3 | 15063128 | ||
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 2.49e-07 | 94 | 50 | 5 | 21542922 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.77e-07 | 457 | 50 | 8 | 32344865 | |
| Pubmed | 3.33e-07 | 10 | 50 | 3 | 12970426 | ||
| Pubmed | Defining a new role of GW182 in maintaining miRNA stability. | 2.03e-06 | 2 | 50 | 2 | 23090477 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 18946079 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20402672 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 9060628 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.03e-06 | 2 | 50 | 2 | 9460924 | |
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 20198652 | ||
| Pubmed | 2.03e-06 | 2 | 50 | 2 | 17938239 | ||
| Pubmed | 2.12e-06 | 263 | 50 | 6 | 34702444 | ||
| Pubmed | 3.34e-06 | 638 | 50 | 8 | 31182584 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 31400113 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 25568082 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 10516026 | ||
| Pubmed | Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. | 6.07e-06 | 3 | 50 | 2 | 15908945 | |
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 21840310 | ||
| Pubmed | 6.07e-06 | 3 | 50 | 2 | 9971820 | ||
| Pubmed | Characterization of the interactions between mammalian PAZ PIWI domain proteins and Dicer. | 1.21e-05 | 4 | 50 | 2 | 14749716 | |
| Pubmed | lncRNA CASC2 inhibits lipopolysaccharide‑induced acute lung injury via miR‑27b/TAB2 axis. | 1.21e-05 | 4 | 50 | 2 | 33174006 | |
| Pubmed | 1.21e-05 | 4 | 50 | 2 | 7983737 | ||
| Pubmed | Tudor-SN-mediated endonucleolytic decay of human cell microRNAs promotes G1/S phase transition. | 1.21e-05 | 4 | 50 | 2 | 28546213 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 1.21e-05 | 4 | 50 | 2 | 10469592 | |
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 17671087 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 19324964 | ||
| Pubmed | 2.02e-05 | 5 | 50 | 2 | 28559278 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 2.02e-05 | 5 | 50 | 2 | 11401426 | |
| Pubmed | Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes. | 2.02e-05 | 5 | 50 | 2 | 22484317 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 23535175 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 28683311 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 19383768 | ||
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 17962186 | ||
| Pubmed | Cadherin complexes recruit mRNAs and RISC to regulate epithelial cell signaling. | 4.23e-05 | 7 | 50 | 2 | 28877994 | |
| Pubmed | 4.23e-05 | 7 | 50 | 2 | 34518544 | ||
| Pubmed | Functional dissection of the human TNRC6 (GW182-related) family of proteins. | 4.23e-05 | 7 | 50 | 2 | 19470757 | |
| Pubmed | Mili interacts with tudor domain-containing protein 1 in regulating spermatogenesis. | 5.64e-05 | 8 | 50 | 2 | 19345100 | |
| Pubmed | NCOA6 differentially regulates the expression of the CYP2C9 and CYP3A4 genes. | 5.64e-05 | 8 | 50 | 2 | 21292004 | |
| Pubmed | The HIV-1 Nef protein binds argonaute-2 and functions as a viral suppressor of RNA interference. | 5.64e-05 | 8 | 50 | 2 | 24023945 | |
| Pubmed | 5.80e-05 | 472 | 50 | 6 | 38943005 | ||
| Pubmed | 6.82e-05 | 486 | 50 | 6 | 20936779 | ||
| Pubmed | 6.91e-05 | 152 | 50 | 4 | 38360978 | ||
| Pubmed | Identification of eight members of the Argonaute family in the human genome. | 7.25e-05 | 9 | 50 | 2 | 12906857 | |
| Pubmed | LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing. | 7.25e-05 | 9 | 50 | 2 | 20616046 | |
| Pubmed | 7.25e-05 | 9 | 50 | 2 | 20014101 | ||
| Pubmed | Human GW182 Paralogs Are the Central Organizers for RNA-Mediated Control of Transcription. | 8.59e-05 | 59 | 50 | 3 | 28813667 | |
| Pubmed | Association of a common AGO1 variant with lung cancer risk: a two-stage case-control study. | 9.05e-05 | 10 | 50 | 2 | 20721975 | |
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 10847592 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 12446761 | ||
| Pubmed | 1.10e-04 | 11 | 50 | 2 | 36613751 | ||
| Pubmed | 1.32e-04 | 12 | 50 | 2 | 12189208 | ||
| Pubmed | 1.33e-04 | 549 | 50 | 6 | 38280479 | ||
| Pubmed | 1.43e-04 | 70 | 50 | 3 | 34255829 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.49e-04 | 351 | 50 | 5 | 38297188 | |
| Pubmed | 1.78e-04 | 1429 | 50 | 9 | 35140242 | ||
| Pubmed | Mammalian miRNA RISC recruits CAF1 and PABP to affect PABP-dependent deadenylation. | 1.82e-04 | 14 | 50 | 2 | 19716330 | |
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 21791611 | ||
| Pubmed | 1.82e-04 | 14 | 50 | 2 | 12482968 | ||
| Pubmed | Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. | 1.82e-04 | 14 | 50 | 2 | 12039952 | |
| Pubmed | 2.10e-04 | 15 | 50 | 2 | 10567404 | ||
| Pubmed | GW182 proteins directly recruit cytoplasmic deadenylase complexes to miRNA targets. | 2.10e-04 | 15 | 50 | 2 | 21981923 | |
| Pubmed | Tooth morphogenesis and ameloblast differentiation are regulated by micro-RNAs. | 2.40e-04 | 16 | 50 | 2 | 20102707 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 2.76e-04 | 218 | 50 | 4 | 33378226 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 3.03e-04 | 908 | 50 | 7 | 19274049 | |
| Pubmed | 3.05e-04 | 18 | 50 | 2 | 18664271 | ||
| Pubmed | Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. | 3.05e-04 | 18 | 50 | 2 | 19047128 | |
| Pubmed | Early embryonic lethality of mice with disrupted transcription cofactor PIMT/NCOA6IP/Tgs1 gene. | 3.41e-04 | 19 | 50 | 2 | 22982455 | |
| Pubmed | 3.59e-04 | 425 | 50 | 5 | 24999758 | ||
| Pubmed | 3.79e-04 | 20 | 50 | 2 | 11877444 | ||
| Pubmed | 4.18e-04 | 21 | 50 | 2 | 19596656 | ||
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 4.59e-04 | 22 | 50 | 2 | 26886794 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 5.03e-04 | 23 | 50 | 2 | 30962207 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 5.81e-04 | 724 | 50 | 6 | 36232890 | |
| Pubmed | 5.95e-04 | 25 | 50 | 2 | 19138993 | ||
| Pubmed | 5.95e-04 | 25 | 50 | 2 | 26098214 | ||
| Pubmed | 6.20e-04 | 733 | 50 | 6 | 34672954 | ||
| Pubmed | 6.44e-04 | 26 | 50 | 2 | 19898466 | ||
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 6.64e-04 | 118 | 50 | 3 | 37105989 | |
| Pubmed | Notch2 regulates BMP signaling and epithelial morphogenesis in the ciliary body of the mouse eye. | 6.95e-04 | 27 | 50 | 2 | 23676271 | |
| Pubmed | 7.48e-04 | 28 | 50 | 2 | 30037996 | ||
| Pubmed | 7.96e-04 | 289 | 50 | 4 | 37132043 | ||
| Pubmed | 8.02e-04 | 29 | 50 | 2 | 25681748 | ||
| Pubmed | 8.02e-04 | 29 | 50 | 2 | 31330130 | ||
| Pubmed | 8.02e-04 | 29 | 50 | 2 | 23077214 | ||
| Pubmed | 9.62e-04 | 1103 | 50 | 7 | 34189442 | ||
| Pubmed | 9.63e-04 | 529 | 50 | 5 | 14621295 | ||
| Pubmed | 9.77e-04 | 32 | 50 | 2 | 19542561 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 1.02e-03 | 807 | 50 | 6 | 22681889 | |
| Pubmed | 1.03e-03 | 808 | 50 | 6 | 20412781 | ||
| Pubmed | 1.09e-03 | 140 | 50 | 3 | 16778019 | ||
| Pubmed | Proximity labeling reveals dynamic changes in the SQSTM1 protein network. | 1.19e-03 | 322 | 50 | 4 | 39098523 | |
| Pubmed | ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2. | 1.38e-03 | 38 | 50 | 2 | 30629181 | |
| Cytoband | 12q12 | 1.17e-03 | 47 | 49 | 2 | 12q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q12 | 1.54e-03 | 54 | 49 | 2 | chr3q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q12 | 2.09e-03 | 63 | 49 | 2 | chr12q12 | |
| GeneFamily | Argonaute/PIWI family | 8.44e-05 | 8 | 32 | 2 | 408 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 6.98e-07 | 166 | 45 | 5 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.62e-07 | 169 | 45 | 5 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-06 | 184 | 45 | 5 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.16e-06 | 184 | 45 | 5 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1|World / Lineage, Cell type, age group and donor | 1.22e-06 | 186 | 45 | 5 | 09d95daa3387a4814cffaa4b798cc2810c3759d0 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.26e-06 | 187 | 45 | 5 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.43e-06 | 192 | 45 | 5 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.47e-06 | 193 | 45 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-06 | 198 | 45 | 5 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.66e-06 | 198 | 45 | 5 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.66e-06 | 198 | 45 | 5 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.66e-06 | 198 | 45 | 5 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.66e-06 | 198 | 45 | 5 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.21e-05 | 140 | 45 | 4 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 2.84e-05 | 174 | 45 | 4 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.97e-05 | 176 | 45 | 4 | 1af28b701c4598ce761f85adbd5d79e4918d265a | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 3.18e-05 | 179 | 45 | 4 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-05 | 179 | 45 | 4 | 4f6ca313b78aa93557937a046c44dcf8bcc9963c | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 3.46e-05 | 183 | 45 | 4 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.46e-05 | 183 | 45 | 4 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.46e-05 | 183 | 45 | 4 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 3.46e-05 | 183 | 45 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | IPF-Epithelial-ATI|IPF / Disease state, Lineage and Cell class | 3.46e-05 | 183 | 45 | 4 | c0a3541c45bd0c587603521f392f42dd86c3c35b | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.54e-05 | 184 | 45 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.61e-05 | 185 | 45 | 4 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 3.61e-05 | 185 | 45 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 3.61e-05 | 185 | 45 | 4 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 3.61e-05 | 185 | 45 | 4 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | IPF-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 3.69e-05 | 186 | 45 | 4 | d436ee6cabbde8553ec5e6e55022274090d9f41a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.77e-05 | 187 | 45 | 4 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Control-Epithelial-ATI|Control / Disease state, Lineage and Cell class | 3.77e-05 | 187 | 45 | 4 | fdd1c57b61ca9392ac27661a82729f37593df63c | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 3.93e-05 | 189 | 45 | 4 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.93e-05 | 189 | 45 | 4 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.01e-05 | 190 | 45 | 4 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.01e-05 | 190 | 45 | 4 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.09e-05 | 191 | 45 | 4 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 4.18e-05 | 192 | 45 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 4.18e-05 | 192 | 45 | 4 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.44e-05 | 195 | 45 | 4 | a71ba5e4043e2d35a45a2c60a96b087e31832345 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.62e-05 | 197 | 45 | 4 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.80e-05 | 199 | 45 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.80e-05 | 199 | 45 | 4 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Sepsis-URO-Lymphocyte-B-Plasmablast|URO / Disease, condition lineage and cell class | 4.80e-05 | 199 | 45 | 4 | 0df6cafb7f3b607cbe80b6f25b4fd62d421d01ee | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Fibroblasts-4|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 4.89e-05 | 200 | 45 | 4 | 54b18c92daaa3b3368c0c46134b0c27e10c8dbb0 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.57e-04 | 137 | 45 | 3 | 9324b55eac55e0cc1e8e450a4b5374d12e9587a3 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.57e-04 | 137 | 45 | 3 | 032f8409d0d179e254c8ff632afbda78852a9889 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Acta2Rgs5.Kcnj8_(Mural.Acta2Rgs5.Kcnj8)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.57e-04 | 137 | 45 | 3 | 265a4a50e48b13c8b3b0730f818235f71fbd6baa | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Gabrg1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.80e-04 | 140 | 45 | 3 | 2c44e8cc5190226049be7ebc465d685393e701c4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.02e-04 | 154 | 45 | 3 | 5ed64bbf603290e6dc34f81d145982690b89dd0d | |
| ToppCell | AT1-AT2_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.12e-04 | 155 | 45 | 3 | 010e45ef4b505bf419ea41e4d1619521d1c78319 | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.92e-04 | 163 | 45 | 3 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 5.92e-04 | 163 | 45 | 3 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | Adult-Immune-B_cell-D231|Adult / Lineage, Cell type, age group and donor | 5.92e-04 | 163 | 45 | 3 | 4f5821299b265663c7d0352b28285f56e1988841 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 6.03e-04 | 164 | 45 | 3 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.14e-04 | 165 | 45 | 3 | 3c8baed838eccb6e720bacb7458f087647dc1222 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.25e-04 | 166 | 45 | 3 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 6.25e-04 | 166 | 45 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.36e-04 | 167 | 45 | 3 | 720dc5855c856b478b5ca90156b30bfcc5518d60 | |
| ToppCell | mild_COVID-19_(asymptomatic)-pDC|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.47e-04 | 168 | 45 | 3 | 968405ea56f7d001ef83ff9274610923c3b2d55d | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 168 | 45 | 3 | 0e8b0e6399c6c82c9c0e546f7316f902de0765d3 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D175|Adult / Lineage, Cell type, age group and donor | 6.47e-04 | 168 | 45 | 3 | 14071b961c9bdb54a8259b12a88237b802cbde36 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-04 | 169 | 45 | 3 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | COVID-19_Convalescent|World / Disease condition and Cell class | 6.81e-04 | 171 | 45 | 3 | 0784fcc45d7b5afba004dd65247d17f452f52b30 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.81e-04 | 171 | 45 | 3 | 3d60e7ecf25e4b781ba2387671b2aad247fb75ff | |
| ToppCell | URO-Lymphocyte-B-Plasmablast|URO / Disease, Lineage and Cell Type | 6.92e-04 | 172 | 45 | 3 | 48888ef50ac784b38aca81da68f8a94ce09c670d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 172 | 45 | 3 | 33c201aaa98acbf1901b6fa6ce0d3ff8012a4d94 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 173 | 45 | 3 | 4f0c065e876197ad8cae7856669f09e37ecafa3f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-plasmacytoid_dendritic_cell-plasmacytoid_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.04e-04 | 173 | 45 | 3 | 9bbea566964281f47bf75d665b7d69ba8326e207 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|Mesenchymal_cells / Lineage and Cell class | 7.16e-04 | 174 | 45 | 3 | 430e3cd61bc2a471959faa40e817aa4dd7d82d28 | |
| ToppCell | Influenza_Severe-B_intermediate|Influenza_Severe / Disease group and Cell class | 7.16e-04 | 174 | 45 | 3 | 4276bdaac53aebd3084323a90ecde572d3177446 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.16e-04 | 174 | 45 | 3 | 7e7b13de916cd4fa0fa6fb06e6b4942877afa9fb | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | 91cb819a1786020713b7e64480de0545380daae9 | |
| ToppCell | COVID-19_Convalescent|World / Disease group, lineage and cell class | 7.28e-04 | 175 | 45 | 3 | 4d6343308ec5a644af1432ef0f63dcaf9f02e4bc | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 7.28e-04 | 175 | 45 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | PBMC-Convalescent|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.28e-04 | 175 | 45 | 3 | 4dc4d0d3bf887a52adbe9d81c8a03fc95bc7a4b0 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ionocytes|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.28e-04 | 175 | 45 | 3 | 13b8f7dc38c90b74d4a20a84a8705d8e2ec244f6 | |
| ToppCell | PBMC-Convalescent|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.28e-04 | 175 | 45 | 3 | d3f897271b64872535213a3dc27b9330255ef9ee | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.40e-04 | 176 | 45 | 3 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | Adult-Immune-B_cell|Adult / Lineage, Cell type, age group and donor | 7.40e-04 | 176 | 45 | 3 | 4aa00dcde907ad83d3aa4bb10439b7b5c4be1e5d | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 7.40e-04 | 176 | 45 | 3 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | (06)_Krt4/13+-(2)_48hpi|(06)_Krt4/13+ / shred by cell type and Timepoint | 7.45e-04 | 40 | 45 | 2 | 1e42cd186ee06ac9345e16ede649a72c15bdf2f8 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-04 | 177 | 45 | 3 | 4672cc75225a4a23b298afa8ce439628262519db | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-04 | 177 | 45 | 3 | a58c93be9767e3fe8fbb6b0db1210d3a33aac662 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Zbtb32+_B_cell-Zbtb32+_B_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.52e-04 | 177 | 45 | 3 | 3ed383e5c0b15d9d5e75b98cf6d10609f48fc422 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.65e-04 | 178 | 45 | 3 | ccea3c8908d72f5fecd151a133048c8e9758304c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Zbtb32+_B|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-04 | 178 | 45 | 3 | 9b932b677ae05ac6e12cd6ce97789f8c10e4790b | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | 056df2aaff750e0e283e7da78fcc3c90c366aac0 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.77e-04 | 179 | 45 | 3 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.77e-04 | 179 | 45 | 3 | f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 7.90e-04 | 180 | 45 | 3 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | normal_Pleural_Fluid-Myeloid_cells-CD141+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 7.90e-04 | 180 | 45 | 3 | a0b35067b6f2dbd8145da8bab760e9f650f045b0 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | 3dcb74b28f93be35ddf4de1937f7e30b25e11927 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.02e-04 | 181 | 45 | 3 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.02e-04 | 181 | 45 | 3 | 7679a5980011d6dfb1aaca7abf678c29b6f819bb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | ef65b095f4240d61cfd4a59aec19d72d324dba1d | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.15e-04 | 182 | 45 | 3 | 97a805783a1f2b055c21307db250e3688674eff3 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 8.15e-04 | 182 | 45 | 3 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | COPD-Epithelial-ATI|World / Disease state, Lineage and Cell class | 8.15e-04 | 182 | 45 | 3 | e95d946a43b1579af199900bb0e3eacbb9d65300 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.28e-04 | 183 | 45 | 3 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| Disease | Myeloid Leukemia | 3.43e-04 | 18 | 45 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 3.43e-04 | 18 | 45 | 2 | C0023466 | |
| Disease | Mammary Neoplasms, Experimental | 1.72e-03 | 155 | 45 | 3 | C0024668 | |
| Disease | vital capacity | 2.50e-03 | 1236 | 45 | 7 | EFO_0004312 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QQPPPAQQQPAGTFY | 476 | Q2M2I8 | |
| APENPQPDPFINRNY | 6 | A6NJG6 | |
| PPNNARAPSPQVVYQ | 1086 | Q68CP9 | |
| PPRVYQPPTYNRIIN | 221 | Q9UKU9 | |
| NILLPQGRPPVFQQP | 576 | Q9UKV8 | |
| PLLGQPLQYNPPAVL | 931 | Q15032 | |
| RLAQQQQQLYAPPPP | 826 | Q96EV2 | |
| IPGAPVQPVVLRYPN | 226 | Q8NF37 | |
| AAQARPSPQLPQYPG | 1916 | Q86YW9 | |
| PSPQLPQYPGLQQAQ | 1921 | Q86YW9 | |
| NIQLPPGYQPPNLAI | 716 | Q8N201 | |
| YVLGVQVPPQVQPGP | 1156 | Q8NDA2 | |
| QYPPQELFPRGTNPF | 496 | Q6UXY1 | |
| PQVGTPQREPQRNFY | 1486 | Q8IZD2 | |
| YPEAYQGPPVNQLPL | 641 | Q8IV76 | |
| PGYPSQPVEQRPLQQ | 971 | Q14686 | |
| GYFLGQPIPQPRPQR | 776 | Q96MT3 | |
| QPIPQPRPQRFAYYT | 781 | Q96MT3 | |
| LPQYNNCPPPQAAVQ | 651 | Q9YNA8 | |
| LPQYNNCPPPQAAVQ | 651 | P62683 | |
| LPQYNNCPPPQAAVQ | 651 | Q7LDI9 | |
| LPQYNNCPPPQAAVQ | 651 | P63130 | |
| LPQYNNCPPPQVAVQ | 651 | P63126 | |
| LPQYNNCPPPQAAVQ | 651 | P62684 | |
| PLNPPQELLNVYPNN | 1306 | Q9P2K1 | |
| NPYAQPSPIRNLKQP | 106 | Q0VF96 | |
| QRPQPDPYQILGPTS | 256 | Q01543 | |
| NQYLQPTLPPVVIGP | 131 | P36894 | |
| VLPIPQQVVPYPQRA | 176 | P05814 | |
| PQIPQYQPLGQQVPH | 46 | P27658 | |
| PLPRTYPQNLGLLPN | 226 | A8MTA8 | |
| GQPREPQVYTLPPSQ | 221 | P01861 | |
| LFPYQQPPWQIPQRL | 166 | Q9NRM1 | |
| ASQQPGYIQPRPQPP | 26 | Q96J94 | |
| PIPNYQPPEGRYNDI | 181 | Q9NQ50 | |
| SRNFQYPQPPLKPRG | 1016 | Q7Z5M5 | |
| PPPVLNSPQGNSIYI | 201 | Q9NYJ8 | |
| PQPQAQPPGGQKQYV | 61 | P22670 | |
| NPRLPQGAPQQFPYP | 1156 | Q15788 | |
| AQPQLPYSQAAPPVQ | 601 | Q15714 | |
| QPQGIPQPGYNPYRH | 171 | Q9Y6Y8 | |
| LPQYNNCPPPQVAVQ | 651 | P63128 | |
| LFNFIPLNGPPYNPL | 421 | Q6DJT9 | |
| IGPPIPQNQRFIPIN | 806 | Q01973 | |
| PQNQRFIPINGYPIP | 811 | Q01973 | |
| PRYDQPPPVTYQPQQ | 271 | Q9H4B6 | |
| AGYGAQQPQAPPQQP | 251 | Q92734 | |
| QLSPGQYNVLPAPVP | 136 | Q8N801 | |
| PQQGQEPYLPPCQDQ | 66 | Q5T870 | |
| SQQTYAVQPPLPLPG | 181 | Q15561 | |
| SFQPQPVQPQQGYIP | 126 | O43670 | |
| LRPQQFQFYQPQGIP | 546 | Q8TEC5 | |
| VHFPPQDQRPQGQYP | 546 | Q9C0D7 | |
| QPQQQPQALPRYPRE | 121 | Q8NDV7 | |
| PPPPGYHQNGVIRNQ | 956 | Q12965 | |
| PQDQYPPFRFGTVPN | 671 | Q14957 |